首页 / 技术领域 / 氧四环素 / 专利数据
序号 专利名 申请号 申请日 公开(公告)号 公开(公告)日 发明人
181 9-(substituted glycyl) amido - 6-demethyl-6-deoxytetracyclines as antibiotic agents EP93110689.2 1993-07-05 EP0582829A1 1994-02-16 Sum, Phaik-Eng; Lee, Ving J.; Testa, Raymond T.

The invention provides compounds of the formula:

wherein R, R¹ and W are defined in the specification. These compounds are useful as antibiotic agents.

182 7-(Substituted)-9- (substituted glycyl)-amido)-6-demethyl-6-deoxytetracyclines EP93107717.6 1993-05-12 EP0582788A1 1994-02-16 Sum, Phaik-Eng; Lee, Ving J.; Testa, Raymond T.

The invention provides compounds of the formula:

wherein R, R³, R⁴ and W are defined in the specification. These compounds are useful as antibiotic agents.

183 Novel 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines EP92114281.6 1992-08-21 EP0536515A1 1993-04-14 Hlavka, Joseph J.; Sum, Phaik-Eng; Gluzman, Yakov; Lee, Ving J.; Ross, Adma A.

Novel 7-substituted-9-(substituted amino)-6-demethyl-6-deoxytetracycline compounds having activity against a wide spectrum of organisms including organisms which are resistant to tetracyclines are disclosed. Also disclosed are intermediates and methods for making the novel compounds of the present invention.

184 6-deoxy-6-hydroperoxy dehydrotetracyclines and process utilizing the same US19959062 1962-06-04 US3146265A 1964-08-25 SCOTT ALASTAIR I; BEDFORD COLIN T
185 6-deoxy-6-demethyl-6-methylene-5-oxytetracyclines US7644160 1960-12-19 US2984686A 1961-05-16 BLACKWOOD ROBERT K; RENNHARD HANS H; BEEREBOOM JOHN J; STEPHENS JR CHARLES R
186 9-(SUBSTITUTED AMINO)-ALPHA-6-DEOXY-5-OXY TETRACYCLINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ANTIBIOTICS PCT/IB1995000026 1995-01-12 WO1995022529A1 1995-08-24 PFIZER INC.
This invention relates to compounds of formula (I) wherein R<1> is hydrogen or -CH2NR<5>R<6>; R<2> is hydrogen or R<4>(CH2)nCO-; n is an integer from 0 to 4; R<3> is R<8>(CH2)mCO- or R<8>(CH2)mSO2-; m is an integer from 0 to 4; R<4>, R<5>, R<6> and R<8> are defined as in the specification and the pharmaceutically acceptable salts of such compounds. Compounds of formula (I) exhibit antibiotic activity against a wide range of gram-positive and gram-negative organisms, including organisms that are resistant to tetracycline antibiotics.
187 7-Substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines US11145508 2005-06-03 USRE40183E1 2008-03-25 Joseph J. Hlavka; Phaik-Eng Sum; Yakov Gluzman; Ving J. Lee; Adma A. Ross
The invention is drawn to 7-substituted-9-(substituted amino)-6-demethyl-6-deoxytetracycline compounds of the formula wherein R, X, R5 and R6 are defined in the specification. The compounds of the invention are useful as broad spectrum antibiotics.
188 2,3-oxidosqualene-lanosterol cyclase inhibitors US09939872 2001-08-27 US20020068753A1 2002-06-06 Jean Ackermann; Johannes Aebi; Alexander Chucholowski; Henrietta Dehmlow; Olivier Morand; Sabine Wallbaum; Thomas Weller
The present invention relates to piperidine derivatives useful for the treatment and/or prophylaxis of diseases which are associated with 2,3-oxidosqualene-lanosterol cyclase such as hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones, tumors and/or hyperproliferative disorders, and treatment and/or prophylaxis of impaired glucose tolerance and diabetes.
189 2,3-oxidosqualene-lanosterol cyclase inhibitors US09925188 2001-08-09 US20020045777A1 2002-04-18 Jean Ackermann; Johannes Aebi; Denise Blum; Alexander Chucholowski; Henrietta Dehmlow; Hans-Peter Maerki; Olivier Morand; Rene Trussardi; Elisabeth von der Mark; Sabine Wallbaum; Thomas Weller
The present invention relates to aminocyclohexanol derivatives useful for the treatment and/or prophylaxis of diseases which are associated with 2,3-oxidosqualene-lanosterol cyclase such as hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones, tumors and/or hyperproliferative disorders, and treatment and/or prophylaxis of impaired glucose tolerance and diabetes.
190 9-amino-7-(substituted)-6-demethyl-6-deoxytetracyclines US219568 1994-03-29 US5401863A 1995-03-28 Joseph J. Hlavka; Phaik-Eng Sum; Yakov Gluzman; Ving J. Lee
Novel 9-amino-7-(substituted amino)-6-demethyl-6-deoxytetracyclines having activity against a wide spectrum of organisms including organisms which are resistant to tetracyclines are disclosed. Also disclosed are intermediates and methods for making the novel compounds of the present invention.
191 Method for the production of 9-amino-6-demethyl-6-deoxytetracycline US928587 1992-08-13 US5248797A 1993-09-28 Phaik-Eng Sum
The invention relates to a novel method for producing [4S-(4alpha, 12aalpha)]-9-amino-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3, 10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide, hereinafter called 9-amino-6-demethyl-6-deoxytetracycline, which compound is a valuable intermediate for synthesis of tetracyclines.
192 Process for the production of alpha-6-deoxytetracyclines and hydrogenation catalyst useful therein US477571 1990-02-09 US4990636A 1991-02-05 Jagmohan Khanna; Kiran Bala; Inder P. S. Grover
A coordination compound useful as a hydrogenation catalyst, having the formula: ##STR1## wherein Ph is phenyl; R is hydrogen or C.sub.1 -C.sub.4 alkyl; and X is chloro, bromo or iodo. This compound is particularly useful as a homogeneous hydrogenation catalyst in the production of alpha-6-deoxytetracyclines, particularly the antibiotic doxycycline. The desired alpha-6-deoxy product is produced in high yields and stereospecificities, the process requiring the use of minimal quantities of rhodium metal in the hydrogenation catalyst per mole of the 6-methylenetetracycline hydrogenated.
193 Process for the production of alpha-6-deoxytetracyclines and hydrogenation catalyst useful therein US263721 1988-10-28 US4902447A 1990-02-20 Jagmohan Khanna; Kiran Bala; Inder P. S. Grover
A coordination compound useful as a hydrogenation catalyst, having the formula: ##STR1## wherein Ph is phenyl; R is hydrogen or C.sub.1 -C.sub.4 alkyl; and X is chloro, bromo or iodo. This compound is particularly useful as a homogeneous hydrogenation catalyst in the production of alpha-6-deoxytetracyclines, particularly the antibiotic doxycycline. The desired alpha-6-deoxy product is produced in high yields and stereospecificities, the process requiring the use of minimal quantities of rhodium metal in the hydrogenation catalyst per mole of the 6-methylenetetracycline hydrogenated.
194 Process for producing 7-amino-6-demethyl-6-deoxytetracycline US201872 1988-06-03 US4849136A 1989-07-18 Yutaka Saito; Masaji Kasai
This invention provides a new process for producing 7-amino-6-demethyl-6-deoxytetracycline (Compound 3) which is an intermediate for the synthesis of minocycline.Compound 3 can be obtained by reduction of Compound 1 using a dithionite as reducing agent.This invention also provides a method to produce Compound 3 from Compound 2 in one pot. ##STR1## (wherein Ar denotes a substituted aryl group, and X stands for the residue of a mineral acid from which hydrogen atom has been eliminated).
195 Hydrolysis of 2-decarboxamido-2-cyano-6-deoxy-tetracycline derivatives US13411961 1961-08-28 US3069467A 1962-12-18 BEEREBOOM JOHN J; KENNETH BUTLER
196 2,3-oxidosqualene-lanosterol cyclase inhibitors US09939872 2001-08-27 US06964974B2 2005-11-15 Jean Ackermann; Johannes Aebi; Alexander Chucholowski; Henrietta Dehmlow; Olivier Morand; Sabine Wallbaum; Thomas Weller
The present invention relates to piperidine derivatives useful for the treatment and/or prophylaxis of diseases which are associated with 2,3-oxidosqualene-lanosterol cyclase such as hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones, tumors and/or hyperproliferative disorders, and treatment and/or prophylaxis of impaired glucose tolerance and diabetes.
197 2,3-oxidosqualene-lanosterol cyclase inhibitors US09925188 2001-08-09 US06858651B2 2005-02-22 Jean Ackermann; Johannes Aebi; Denise Blum; Alexander Chucholowski; Henrietta Dehmlow; Hans-Peter Maerki; Olivier Morand; Rene Trussardi; Elisabeth von der Mark; Sabine Wallbaum; Thomas Weller
The present invention relates to aminocyclohexanol derivatives useful for the treatment and/or prophylaxis of diseases which are associated with 2,3-oxidosqualene-lanosterol cyclase such as hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones, tumors and/or hyperproliferative disorders, and treatment and/or prophylaxis of impaired glucose tolerance and diabetes.
198 Method of using tetracycline compounds for inhibition of endogenous nitric oxide production US697815 1996-08-30 US5789395A 1998-08-04 Ashok R. Amin; Steven B. Abramson; Lorne M. Golub; Nungavaram S. Ramamurthy; Thomas F. McNamara; Robert A. Greenwald; Howard Trachtman
A method is disclosed for inhibiting endogenous production of nitric oxide (NO) in an in vivo, in vitro, or ex vivo mammalian system. The method employs a tetracycline compound to inhibit production of NO and/or to inhibit the expression or activity of an inducible isoform of nitric oxide synthase (iNOS). Preferably, the tetracycline compound has inhibitory activity for metalloproteinases. Also it is preferred that the tetracycline compound is provided to the mammalian system in an amount which has little or no antibacterial activity in the system. Accordingly, preferred tetracycline compounds are tetracycline compounds which have be modified to reduce or eliminate their antimicrobial activity. The method can be used to treat medical conditions in mammals characterized by NO production mediated by iNOS, including, for example, inflammatory conditions.
199 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines US286096 1994-08-04 US5494903A 1996-02-27 Joseph J. Hlavka; Phaik-Eng Sum; Yakov Gluzman; Ving J. Lee; Adma A. Ross
The invention is drawn to 7-substituted-9-(substituted amino)-6-demethyl-6-deoxytetracycline compounds of the formula ##STR1## wherein R, X, R.sup.5 and R.sup.6 are defined in the specification. The compounds of the invention are useful as broad spectrum antibiotics.
200 Process for producing 7-dimethylamino-6-demethyl-6-deoxytetracycline US222886 1988-07-22 US4918208A 1990-04-17 Ryoichi Hasegawa; Hiroaki Ohno; Kazuaki Sano; Yoshinori Saito
A process for producing 7-dimethylamino-6-demethyl-6-deoxytetracycline (minocycline) which comprises treating the reaction liquid containing minocycline and formaldehyde with hydroxylamine or urea, the reaction liquid being obtained after reductive methylation of 7-amino-6-demethyl-6-deoxytetracycline by using aldehyde, then subjecting the reaction liquid to an adsorption treatment with a nonionic adsorption resin (adsorbent), and subsequently eluting the intended product adsorbed to the adsorbent.
QQ群二维码
意见反馈